{
  "id": 2659,
  "text": "Gynecol Oncol 103, 960-965 (2006).466.Yahata, T., et al.Conservative treatment of stage IA1 adenocarcinoma of the cervix during pregnancy.Gynecol Oncol 109, 49-52 (2008).467.Reynolds, E.A., et al.Analysis of outcomes of microinvasive adenocarcinoma of the uterine cervix by treatment type.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: Gynecol Oncol 103, 960-965 (2006).466.Yahata, T., et al.Conservative treatment of stage IA1 adenocarcinoma of the cervix during pregnancy.Gynecol Oncol 109, 49-52 (2008).467.Reynolds, E.A., et al.Analysis of outcomes of microinvasive adenocarcinoma of the uterine cervix by treatment type.\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "在妊娠期间诊断为宫颈IA1期腺癌的患者，保守治疗的选择包括锥切术和密切随访。锥切术可以通过冷刀锥切（cold knife conization）或环形电切术（LEEP/LLETZ）实现，目的是在保留子宫的同时，彻底切除病变组织，并为进一步病理学评估提供组织样本。\n\n治疗效果方面，研究显示，对于病灶局限于宫颈、无脉管浸润的IA1期腺癌患者，锥切术具有较高的病变清除率，并伴随较低的复发风险。然而，为确保孕期母胎安全，术后需密切监测，包括影像学检查和定期阴道镜评估，从而及时发现可能的残留病变或进展。\n\n总体而言，在妊娠保守治疗的同时，需要与患者充分沟通，以权衡病情控制、妊娠继续以及潜在风险之间的平衡，制定个体化的管理方案。",
  "query": "根据<text>内容创建的问题如下：\n\n**在妊娠期间诊断为宫颈IA1期腺癌的患者，有哪些保守治疗的选择，及其治疗效果如何？**",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 根据<text>内容创建的问题如下：\n\n**在妊娠期间诊断为宫颈IA1期腺癌的患者，有哪些保守治疗的选择，及其治疗效果如何？**\n\n<reference text>: Gynecol Oncol 103, 960-965 (2006).466.Yahata, T., et al.Conservative treatment of stage IA1 adenocarcinoma of the cervix during pregnancy.Gynecol Oncol 109, 49-52 (2008).467.Reynolds, E.A., et al.Analysis of outcomes of microinvasive adenocarcinoma of the uterine cervix by treatment type.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "在妊娠期间诊断为宫颈IA1期腺癌的患者，保守治疗的选择包括锥切术和密切随访。锥切术可以通过冷刀锥切（cold knife conization）或环形电切术（LEEP/LLETZ）实现，目的是在保留子宫的同时，彻底切除病变组织，并为进一步病理学评估提供组织样本。\n\n治疗效果方面，研究显示，对于病灶局限于宫颈、无脉管浸润的IA1期腺癌患者，锥切术具有较高的病变清除率，并伴随较低的复发风险。然而，为确保孕期母胎安全，术后需密切监测，包括影像学检查和定期阴道镜评估，从而及时发现可能的残留病变或进展。\n\n总体而言，在妊娠保守治疗的同时，需要与患者充分沟通，以权衡病情控制、妊娠继续以及潜在风险之间的平衡，制定个体化的管理方案。"
}